Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Cardiovasc Thorac Ann ; 30(6): 669-678, 2022 Jul.
Article in English | MEDLINE | ID: mdl-34918573

ABSTRACT

BACKGROUND: Healthcare workers are still the front liners in health care services, and have major roles during the COVID-19 pandemic. In a resource-limited country like Indonesia, it is necessary to provide safe screening and management both for patients and healthcare workers to minimize the transmission. We report our experience in the cardiac surgery department on how to provide safe management during the COVID-19 pandemic. METHODS: A retrospective observational study was performed in a single-tertiary-center cardiac surgery department in Surabaya and included all patients who underwent cardiac surgery during the first year of the COVID-19 pandemic. We also collected the patients from a 1-year period before the pandemic as the comparison data. Analysis of the patient characteristics, operative data, and postoperative outcome, was performed. This study also provides our experience in changes of admission in the cardiac surgery preoperative system that can be utilized for others. RESULTS: A total of 179 patients were admitted to and had cardiac surgery. Of these, 3.80% (n = 7) were COVID-19 confirmed by a real-time polymerase chain reaction. Five patients were delayed to have cardiac surgery with no mortality or morbidity reported in these patients. During the period after changes of admission procedural in cardiac surgery patients, there were no healthcare workers infected by COVID-19 by patient transmission in our center (0%). CONCLUSION: Our study reported a systematic screening and that possible delay in cardiac surgery appears to be feasible and safe, both for patients and for healthcare workers during the COVID-19 pandemic.


Subject(s)
COVID-19 , Cardiac Surgical Procedures , Cardiac Surgical Procedures/adverse effects , Humans , Indonesia/epidemiology , Pandemics/prevention & control , Treatment Outcome
2.
Asian Cardiovasc Thorac Ann ; 29(3): 203-207, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33353370

ABSTRACT

BACKGROUND: Sternotomy is a standard approach performed in almost every surgical procedure on the heart and mediastinum. Effective hemostasis of the sternum is required to keep the operative field dry, avoid excessive blood transfusions during surgery, and prevent reoperation due to massive postoperative bleeding, which can further increase morbidity and mortality in patients. Bone wax is a mechanical hemostat commonly used after sternotomy and has been known to affect bone healing, trigger chronic inflammatory reactions, and increase the rate of infection. The application of chitosan, which has intrinsic hemostat ability, as hemostatic material is believed to improve bone healing following sternotomy. This study aimed to compare the effectiveness of bone wax and chitosan on bone healing after sternotomy. METHODS: Median sternotomies were performed on 2 groups of New Zealand White rabbits. Each group of 16 animals received either bone wax or chitosan powder as hemostatic material. The degree of bone healing, the number of foreign-body giant cells, and the number of osteoblasts were evaluated after 6 weeks. RESULTS: Radiographs showed that significantly more animals in the chitosan group had total sternal healing (p = 0.033). Histopathology revealed that the number of foreign-body giant cells was significantly less (p = 0.036) and the number of osteoblasts was significantly greater (p < 0.0001) in the group of animals that received chitosan. CONCLUSION: The use of chitosan as hemostatic material can promote better bone healing compared to bone wax.


Subject(s)
Chitosan/pharmacology , Hemostatics/pharmacology , Palmitates/pharmacology , Sternotomy , Sternum/drug effects , Waxes/pharmacology , Wound Healing/drug effects , Animals , Chitosan/toxicity , Foreign-Body Reaction/chemically induced , Foreign-Body Reaction/pathology , Giant Cells/drug effects , Giant Cells/pathology , Hemostatics/toxicity , Male , Models, Animal , Osteoblasts/drug effects , Osteoblasts/pathology , Palmitates/toxicity , Rabbits , Sternotomy/adverse effects , Sternum/physiopathology , Time Factors , Waxes/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...